Search
Searching Evidence for "Chia" · search everything instead
Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.
79 study records (showing up to 30 per record type)
-
Registered trial NCT06062953 Phase 2 / Phase 3 Not completed: RecruitingEfficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid InsomniaCondition or outcome area: Psychiatric Disorders|Insomnia
-
Registered trial NCT05864846 Phase 4 Not completed: RecruitingA Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis ComplexCondition or outcome area: Tuberous Sclerosis Complex Associated Neuropsychiatric Disease2023-06-29 · Subject: Cannabidiol; abn-cbd, (-)-4-(3-3,4-trans-p-menthadien-[1,8]-yl)olivetol; SCHEMBL16224872 · open the ingredient record · ClinicalTrials.gov
-
Registered trial NCT06149091 Early_Phase 1 Not completed: RecruitingControl of Iatrogenic Endobronchial Bleeding by Tranexamic Acid, Adrenalin and HemagglutinaseCondition or outcome area: Iatrogenic Endobronchial Bleeding2023-12-01 · Subject: Adrenaline; Epinephrine hydrochloride; adrenaline · open the ingredient record · ClinicalTrials.gov
-
Registered trial NCT05861544 Not completed: Enrolling By InvitationNUTRItion-driven Detoxification of OPioid Addicted patiEntsCondition or outcome area: Psychiatry2023-03-23 · Subject: Shi Liu; 石榴; Pomegranate Fruit; Fructus Punixae Granati · open the herb record · ClinicalTrials.gov
-
Registered trial NCT05236894 Early_Phase 1 Completed (results not assessed here)Appeal of Nicotine Pouches Versus Cigarettes in the Ohio Appalachia PopulationCondition or outcome area: Cigarette Smoking-Related Carcinoma
-
Registered trial NCT02104284 Completed (results not assessed here)A Comparative Bronchial Provocation Study With Mannitol and Methacolinie in a Korean PopulationCondition or outcome area: Asthma2011-07 · Subject: MTL; Mannitol; d-mannitol; Osmitrol; Mannitol (VAN); 123897-58-5; M9546_SIAL; NCI-C50362; Mannidex; SDM No. 35 · open the ingredient record · ClinicalTrials.gov
-
Registered trial NCT01291433 Phase 3 Completed (results not assessed here)Trial of Combined Pentoxifylline-tocopherol-clodronate vs Placebo in Radiation-induced Brachial PlexopathyCondition or outcome area: Radiation Induced Brachial Plexopathy2011-03 · Subject: Vitamin E; T1539_SIGMA; NSC 82623; (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol; (+-)-alpha-Tocopherol; BRN 0094012; 5,7,8-Trimethyltocol; (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL; 6-Chromanol, 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-; T3634_SIGMA · open the ingredient record · ClinicalTrials.gov
-
Registered trial NCT01690676 Phase 2 Completed (results not assessed here)Effect of an Apple Polyphenol Extract on Brachial Artery Flow-mediated Vasodilatory FunctionCondition or outcome area: Borderline Hypertension2012-08 · Subject: Epicatechin; l-Epicatechol; epi-Catechol; (3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; SCHEMBL13350313; (.+-.)-Epicatechol; (+/-)-Epicatechin; AC1L5SMJ; L-Epicatechin; Epicatechol, (-)- · open the ingredient record · ClinicalTrials.gov
-
Registered trial NCT04749745 Early_Phase 1 Completed (results not assessed here)Effects of L-theanine on Motor Cortex Excitability in Healthy Subjects: A Paired-Pulse TMS StudyCondition or outcome area: Cortical Excitability|Psychiatric Disorder
-
Registered trial NCT04921527 Phase 3 Not completed: RecruitingChiauranib Plus Weekly Paclitaxel in Patients With Platinum-refractory or Platinum-resistant Recurrent Ovarian CancerCondition or outcome area: Ovarian Cancer|Relapsed or Refractory|Chiauranib|Paclitaxel
-
Registered trial NCT00783705 Phase 2 Completed (results not assessed here)Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial DysplasiaCondition or outcome area: Non-small Cell Lung Cancer|Squamous Lung Dysplasia2008-11 · Subject: Myoinositol; Inositol; inositol b; D-myo-inositol; D-Chiro-Inositol; cocositol; Chiro-inositol; inositol c; KS-00001292; TR-022051 · open the ingredient record · ClinicalTrials.gov
-
Registered trial NCT00061997 Phase 1 Completed (results not assessed here)Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former SmokersCondition or outcome area: Lung Cancer|Precancerous Condition2003-05 · Subject: Myoinositol; Inositol; inositol b; D-myo-inositol; D-Chiro-Inositol; cocositol; Chiro-inositol; inositol c; KS-00001292; TR-022051 · open the ingredient record · ClinicalTrials.gov
-
Registered trial NCT00916526 Completed (results not assessed here)Measurement of Exhaled Nitric Oxide (NO) and Bronchial Provocation Test With Mannitol as a Predictor of Response to Inhaled Corticosteroids in Chronic CoughCondition or outcome area: Cough|Bronchial Hyperreactivity2008-11 · Subject: MTL; Mannitol; d-mannitol; Osmitrol; Mannitol (VAN); 123897-58-5; M9546_SIAL; NCI-C50362; Mannidex; SDM No. 35 · open the ingredient record · ClinicalTrials.gov
-
Registered trial NCT00564824 Phase 3 Completed (results not assessed here)The Impact of Caffeine on Brachial Endothelial Function in Healthy Subjects and in Patients With Ischemic Heart DiseaseCondition or outcome area: Coronary Disease2007-11 · Subject: Caffeine; NCGC00015208-02; DHCplus; KBio2_001781; W222402_ALDRICH; NINDS_000730; EINECS 200-362-1; Spectrum5_000423; BSPBio_001921; KBio1_000730 · open the ingredient record · ClinicalTrials.gov
-
Registered trial NCT00992667 Phase 1 Completed (results not assessed here)Inhaled Apocynin Decreases Reactive Oxygen Species Concentrations in Exhaled Breath Condensate in Mild AsthmaticsCondition or outcome area: Bronchial Asthma2008-06 · Subject: Apocynin; Acetovanillone; acetovanillone; 1-(4-Hydroxy-3-methoxyphenyl)ethanone; InChI=1/C9H10O3/c1-6(10)7-3-4-8(11)9(5-7)12-2/h3-5,11H,1-2H; Ethanone, 1-(4-hydroxy-3-methoxyphenyl)-; AA-504/20839006; 4-Hydroxy-3-methoxyacetophenone; NSC 209524; Acetophenone, 4'-hydroxy-3'-methoxy- · open the ingredient record · ClinicalTrials.gov
-
Registered trial NCT05034107 Completed (results not assessed here)Effects of Diffused Ylang-Ylang Essential Oil Amongst Older Persons With DementiaCondition or outcome area: Dementia|Behavioral and Psychiatric Symptoms of Dementia2021-06-30 · Subject: Yi Lan; 依兰; Fragrant Gananga; Cananga Odorata · open the herb record · ClinicalTrials.gov
-
Registered trial NCT03908892 Not completed: UnknownEffect of Zanthoxylum Nitidum Tincture for Paronychia Caused by AfatinibCondition or outcome area: Paronychia2019-06-12 · Subject: Ru Di Jin Niu; 入地金牛; Shinyleaf Pricklyash; Zanthoxylum Nitidum · open the herb record · ClinicalTrials.gov
-
Registered trial NCT03477825 Completed (results not assessed here)Pilot Study of Triphala and Rubia Cordifolia on Gut Microbiome and SkinCondition or outcome area: Sebum Production|Stool Microbiome|Transepidermal Water Loss|Facial Brrightness|Erythema|Wrinkles|Facial Shine2018-03-12 · Subject: Qian Cao Gen; 茜草根; Indian Madder Root Equivalent Plant: Rubia Schumannina, Rubia Tinctorum , Rubia Oncotricha, Rubia Wallichiana; Rubia Cordifolia · open the herb record · ClinicalTrials.gov
-
Registered trial NCT05115318 Completed (results not assessed here)The Effect of Medical Cannabis on Tics, Premonitory Urge and Psychiatric Comorbidity in Adults With Tourette SyndromeCondition or outcome area: Tourette Syndrome|Cannabis
-
Systematic review registration CRD42023478563 Registered protocol, no results here: Review OngoingEfficacy and Safety of L-Theanine in Neuropsychiatric Disorders: A Systematic ReviewCondition or outcome area: Neuropsychiatric disorders: Neuropsychiatric disorders are a category of medical conditions that encompass both neurological and psychiatric components, affecting the brain's structure and function, leading to various cognitive and emotional disturbances.2023-11-12 · Subject: Theanine; L-Theanine; 3081-61-6; N-Ethyl-L-glutamine; Theanin; Suntheanine; (S)-2-Amino-5-(ethylamino)-5-oxopentanoic acid; N5-Ethyl-L-glutamine; CCRIS 7326; C7H14N2O3 · open the ingredient record
-
Systematic review registration CRD42023438827 Registered protocol, no results here: Review OngoingAccuracy of bronchial challenge testing with mannitol for diagnosis of asthmaCondition or outcome area: Asthma2023-06-23 · Subject: Mtl; Mannitol; D-mannitol; mannitol; 69-65-8; Mannite; Osmitrol; Manna sugar; Cordycepic acid; Osmofundin · open the ingredient record
-
Systematic review registration CRD42023438302 Registered protocol, no results here: Review OngoingAccuracy of bronchial challenge testing with histamine and methacholine in the diagnosis of asthmaCondition or outcome area: Asthma2023-06-21 · Subject: Histamine; 51-45-6; 2-(1H-imidazol-5-yl)ethanamine; 1H-Imidazole-4-ethanamine; Ergamine; Ergotidine; 2-(4-Imidazolyl)ethylamine; 5-Imidazoleethylamine; Eramin; Theramine · open the ingredient record
-
Systematic review registration CRD42023465502 Registered protocol, no results here: Review OngoingAnticholinesterases for Neuropsychiatric Symptoms among Patients with Parkinson's Disease: A proposed systematic review and Meta-analysis of RCTs.Condition or outcome area: Parkinson's disease is a complex neurological disorder primarily known for its motor symptoms, which include rest tremors, muscle rigidity, akinesia, and postural instability. These motor symptoms result from the degeneration of dopamine-producing neurons in the substantia nigra of the brain. However, the scope of PD extends well beyond the classic dopaminergic pathway, involving various neurotransmitter systems and brain regions resulting in non-motor symptoms of PD. These non-motor symptoms ar2023-10-02 · Subject: Galanthamine; Galantamine; 357-70-0; (-)-Galanthamine; Lycoremin; Lycoremine; Jilkon; Galantamina; Galanthaminum; Galantamin · open the ingredient record
-
Systematic review registration CRD42023412516 Registered protocol, no results here: Review OngoingEfficacy and Safety of Cholinesterase Inhibitors, Memantine, and Sodium Oligomannate for the Treatment of Alzheimer’s Disease: a Bayesian network meta-analysisCondition or outcome area: Alzheimer’s disease(AD) is the most common cause of dementia, affecting more than 36 million people worldwide. It has been predicted that by 2050, this figure will more than 115 million.This age-associated neurodegenerative disorder has an insidious onset with progressive deterioration in cognition, functional ability, behavior, and mood. Regarding patients with mild-to-moderate AD, the American Psychiatric Association recommends second generation ChEIs, donepezil, galantamine and rivastigmine f2023-04-09 · Subject: Galanthamine; Galantamine; 357-70-0; (-)-Galanthamine; Lycoremin; Lycoremine; Jilkon; Galantamina; Galanthaminum; Galantamin · open the ingredient record
-
Systematic review registration CRD42023468700 Registered protocol, no results here: Review OngoingMicronutrient status and psychiatric disorders: Mendelian randomization and umbrella reviewCondition or outcome area: Major psychiatric disorders will be studied, including: depressive disorder, an affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. Schizophrenia, a disorder of psychotic depth characterized by delusion formation, hallucinations, emotional disharmony, and regressive behavior. autism spectrum disorder, a childhood disorder characterized by markedly abnormal or impaired development in social interaction and communication and a markedly rest2023-10-13 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
-
Systematic review registration CRD42023468700 Registered protocol, no results here: Review OngoingMicronutrient status and psychiatric disorders: Mendelian randomization and umbrella reviewCondition or outcome area: Major psychiatric disorders will be studied, including: depressive disorder, an affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. Schizophrenia, a disorder of psychotic depth characterized by delusion formation, hallucinations, emotional disharmony, and regressive behavior. autism spectrum disorder, a childhood disorder characterized by markedly abnormal or impaired development in social interaction and communication and a markedly rest2023-10-13 · Subject: Phosphorus; 12185-10-3; 27YLU75U4W; 7723-14-0; P; Red phosphorus; Violet phosphorus; White Phosphorus; Phosphorus 31; Phosphorus 6 · open the ingredient record
-
Systematic review registration CRD42023468700 Registered protocol, no results here: Review OngoingMicronutrient status and psychiatric disorders: Mendelian randomization and umbrella reviewCondition or outcome area: Major psychiatric disorders will be studied, including: depressive disorder, an affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. Schizophrenia, a disorder of psychotic depth characterized by delusion formation, hallucinations, emotional disharmony, and regressive behavior. autism spectrum disorder, a childhood disorder characterized by markedly abnormal or impaired development in social interaction and communication and a markedly rest2023-10-13 · Subject: Cuprum; Copper; 7440-50-8; Cu; Copper powder; Bronze powder; Copper bronze; Copper, elemental; Tatum-T; Arwood copper · open the ingredient record
-
Systematic review registration CRD42023466414 Registered protocol, no results here: Review OngoingEffects of benzoate on cognitive function in neuropsychiatric disorderCondition or outcome area: Neuropsychiatric disorders2023-10-03 · Subject: Benzoate; 766-76-7; Phenylformate; benzoate anion; Benzoic acid, ion(1-); Benzeneformate; Tennplas; Benzenemethanoate; Phenylcarboxylate; Benzenecarboxylate · open the ingredient record
-
Systematic review registration CRD42023409202 Registered protocol, no results here: Review OngoingPeg-asparaginase toxicity in pediatric patients with acute lymphoblastic leukemia: systematic review with monocentric experienceCondition or outcome area: Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children, representing more than a quarter of all pediatric cancers. Acute lymphoblastic leukemia affects the immature forms of white blood cells, called lymphocytes. Pegaspargase, a pegylated form of native Escherichia coli-derived L-asparaginase, is indicated in the USA and EU for the treatment of acute lymphoblastic leukaemia (ALL) as a component of multi-agent chemotherapy in paediatric and adult patients. Numerous
-
Systematic review registration CRD42023471475 Registered protocol, no results here: Review OngoingNew horizons for the study of saffron (Crocus Sativus L.) and its active ingredients in the management of neurological and psychiatric disorders: A systematic review of clinical evidence and mechanismsCondition or outcome area: Saffron, cognition, depression and anxiety, sleep disorders, ADHD, OCD.
-
Systematic review registration CRD42023403252 Registered protocol, no results here: Review OngoingA meta-analysis of the efficacy and safety of traditional Chinese medicine formula Kaixinsan decoction for depressionCondition or outcome area: Depression is a common psychiatric disease with crucial features of depressed mood, diminished interest, and lack of pleasure, and often accompanied by specific physical symptoms, which significantly reduce the patient's quality of life and ability to work and, in severe cases, may even lead to suicidal intentions. The Chinese herbal formula Kaixin San is a safe and effective Chinese medical treatment, which usually achieves the same or even better efficacy than antidepressants with lower side e
-
Systematic review registration CRD42023425989 Registered protocol, no results here: Review OngoingEfficacy of Jinshuibao capsule, Bailing capsule, and Zhiling capsule in the therapy of chronic obstructive pulmonary disease (COPD) based on network meta-analysisCondition or outcome area: Chronic obstructive pulmonary disease (COPD) is a widespread illness. It is primarily characterized by bronchial obstruction and inflammation of the chronic airway, which results in gradually impeding the airflow. Globally, COPD is ranked as the third leading cause of fatalities. As a critical health problem, COPD is a primary cause of chronic morbidity and mortality. Most patients suffer from COPD for years and pass away prematurely due to the disease itself or complications caused by COPD.
-
Systematic review registration CRD42023425989 Registered protocol, no results here: Review OngoingEfficacy of Jinshuibao capsule, Bailing capsule, and Zhiling capsule in the therapy of chronic obstructive pulmonary disease (COPD) based on network meta-analysisCondition or outcome area: Chronic obstructive pulmonary disease (COPD) is a widespread illness. It is primarily characterized by bronchial obstruction and inflammation of the chronic airway, which results in gradually impeding the airflow. Globally, COPD is ranked as the third leading cause of fatalities. As a critical health problem, COPD is a primary cause of chronic morbidity and mortality. Most patients suffer from COPD for years and pass away prematurely due to the disease itself or complications caused by COPD.2023-05-22 · Subject: JinshuibaoJiaonang; 金水宝胶囊; Jin Shui Bao Capsule; Jinshuibao Capsule · open the formula record
-
Systematic review registration CRD42021238804 Registered protocol, no results here: Review OngoingEffectiveness of the Shugan Jieyu capsule against psychiatric symptoms in epilepsy: A protocol for systematic review and meta-analysisCondition or outcome area: Epilepsy is a chronic pathological condition of the brain that causes recurrent seizures. It is known that patients with epilepsy, particularly in the case of treatment-resistant epilepsy which accounts for one third to half, have an increased risk of psychological disorder. Psychiatric symptoms of epilepsy include not only depression, but also fatigue, sleep disturbances, anxiety, and memory problems. The relationship between epilepsy and psychiatric symptoms is known to be bidirectional. Clini2021-03-24 · Subject: Shu Gan Jie Yu Jiao Nang; 舒肝解郁胶囊; Shugan Jieyu Capsule · open the formula record
-
Systematic review registration CRD42021242055 Registered protocol, no results here: Review OngoingComparison of efficacy and safety of Chinese patent medicine in the treatment of chronic bronchitis: A protocol for systematic review and network meta-analysis.Condition or outcome area: Chronic bronchitis is one of the common diseases of respiratory system. It is a chronic nonspecific inflammation of trachea, bronchial mucosa and surrounding tissues. Its clinical symptoms mainly include cough, expectoration, wheezing or shortness of breath. It lasts for 3 months every year for 2 years or more. In traditional Chinese medicine, more and more drugs have been found to be able to treat chronic bronchitis. Many studies have shown that Chinese patent medicine has obvious curative effe
-
Systematic review registration CRD42019118553 Registered protocol, no results here: Review OngoingImmunomodulatory effect of Yupingfeng powder for bronchial asthma in children: a systematic review and meta-analysisCondition or outcome area: Bronchial asthma is the most common chronic respiratory disease in children. The essence of bronchial asthma is the persistent chronic allergic inflammation of the respiratory tract and the related airway hyper-responsiveness. The role of long-term control drugs of bronchial asthma mainly aims at the pathophysiological basis (inflammation) of bronchial asthma. With the in-depth study of the pathogenesis of bronchial asthma, it is believed that immune dysfunction also plays an important role in t
-
Systematic review registration CRD42021249752 Registered protocol, no results here: Review OngoingMeta-analysis of Xiaoqinglong Decoction in the treatment of bronchial asthmaCondition or outcome area: Bronchial asthma is a common chronic inflammatory disease. Its clinical manifestations are recurrent wheezing, shortness of breath, chest tightness or cough. Its effective control rate is poor. In recent years, its prevalence rate has increased year by year in the world. Now clinical research shows that Xiaoqinglong decoction has a good effect in the treatment of bronchial asthma, and the clinical research of integrated traditional Chinese and Western medicine in the treatment of bronchial asthm
-
Systematic review registration CRD42021284372 Registered protocol, no results here: Review Ongoing三金片剂与利沃弗洛沙辛在急性尿路感染治疗中的功效和安全性:系统回顾和元分析Condition or outcome area: Urine tract infection (UTI) is mainly caused by bacteria, including pathogenic Escherichia coli (UPEC)(70%-80%), Klebsiella (6%), Staphylococcus (6%), Enterococcus (5%) and other pathogens. Most UTI is caused by bacteria, so antibiotics are the main drugs for clinical treatment of UTI, which can effectively kill bacteria and relieve clinical symptoms. Despite antibiotic treatment, more than 30% of women develop subsequent infections within 12 months of the initial resolution of symptoms. In addi
-
Systematic review registration CRD42021264528 Registered protocol, no results here: Review OngoingSystematic review and meta-analysis of the efficacy and safety of Sanjin tablet combined with antibiotics in the treatment of acute simple urinary tract infectionCondition or outcome area: Urine tract infection (UTI) is mainly caused by bacteria, including pathogenic Escherichia coli (UPEC)(70%-80%), Klebsiella (6%), Staphylococcus (6%), Enterococcus (5%) and other pathogens. Most UTI is caused by bacteria, so antibiotics are the main drugs for clinical treatment of UTI, which can effectively kill bacteria and relieve clinical symptoms. Despite antibiotic treatment, more than 30% of women develop subsequent infections within 12 months of the initial resolution of symptoms. In addi
-
Systematic review registration CRD42022354604 Registered protocol, no results here: status not recordedEfficacy and safety of Qili Qiangxin capsule in treatment of pulmonary heart disease : a systematic review and meta-analysisCondition or outcome area: Pulmonary heart disease (PHD) is a disease in which pulmonary vascular resistance is increased due to bronchial and lung tissue, thoracic or pulmonary vascular disease, resulting in pulmonary hypertension, followed by structural or/and functional changes in the right ventricle. PHD has a poor prognosis, which has become a rising major public problem that threatens people’s health and quality of life around the world. The etiology of PHD is complex and multifaceted and there is no single mechanisSubject: Qili Qiangxin Jiaonang; 芪苈强心胶囊; Qili Qiangxin Capsule; Qi Li Qiang Xin Capsule · open the formula record
-
Systematic review registration CRD42023400594 Registered protocol, no results here: Review OngoingTraditional Chinese Medicine prescriptions containing Erchen Decoction for Bronchial asthma in children : a systematic review and meta-analysis of randomised controlled trials.Condition or outcome area: In recent years, the treatment of bronchial asthma in children tends to be standardized, but due to its recurrent attacks and poor long-term efficacy, children with bronchial asthma may benefit from other treatment options, such as traditional Chinese medicine. Erchen Decoction is a herbal formula with the function of invigorating the spleen and resolving phlegm, including pinellia ternate, poria cocos and tangerine peel. Chinese doctors often use Erchen Decoction to treat children with asthma.
-
Systematic review registration CRD42023408753 Registered protocol, no results here: Review OngoingDingchuan decoction as adjuvant treatment for bronchial asthma: A protocol for systematic review and meta-analysisCondition or outcome area: Bronchial asthma is a common respiratory disease in clinic. The prevalence of asthma in China increases year by year, which has seriously affected the quality of life of patients. In addition to the conventional treatment in western medicine, traditional Chinese medicine (TCM), as an adjuvant treatment, has been widely used in clinical practice. Dingchuan decoction has a long history of treating lung diseases. In recent years, there are more and more clinical trials of Dingchuan decoction combin
-
Systematic review registration CRD42020158933 Registered protocol, no results here: Review OngoingComparative effectiveness of four Chinese herb formulas for acute asthma: a network meta-analysis and systematic reviewCondition or outcome area: Bronchial asthma is a frequently occurring disease of respiratory system, which is usually diagnosed in children's time. Most of the patients need long-term maintenance treatment. The included studys must be the patients in randomized controlled trial (RCT) who are diagnosed as the acute attack of bronchial asthma for hospitalization or outpatient treatment.
-
Systematic review registration CRD42020158933 Registered protocol, no results here: Review OngoingComparative effectiveness of four Chinese herb formulas for acute asthma: a network meta-analysis and systematic reviewCondition or outcome area: Bronchial asthma is a frequently occurring disease of respiratory system, which is usually diagnosed in children's time. Most of the patients need long-term maintenance treatment. The included studys must be the patients in randomized controlled trial (RCT) who are diagnosed as the acute attack of bronchial asthma for hospitalization or outpatient treatment.
-
Systematic review registration CRD42016049937 Registered protocol, no results here: Review OngoingDing chuan decoction for asthma in children: a systematic review and meta-analysis of effect on effective rate and lung functionCondition or outcome area: Bronchial asthma, health care in children
-
Systematic review registration CRD42021258120 Registered protocol, no results here: Review OngoingA systematic review and meta-analysis of Annao pill in patients with post-stroke depressionCondition or outcome area: Post-stroke depression (PSD) is a common psychiatric sequela, which affects around one-third of stroke patients. Today the majority of PSD patients remain untreated or inadequately treated. Antidepressants (AD) is mainly pharmaceutical treatment for PSD. However, AD is limited by its poor therapeutic effect and increased incidence of adverse events (AEs). Annao pill, a traditional Chinese patent medicine, has been widely used to remit the symptom of post-stroke depression. The need to find evide
-
Systematic review registration CRD42021249810 Registered protocol, no results here: Review OngoingVitamin D Status and Tic Disorder: A Systematic Review and Meta-Analysis of Observational studiesCondition or outcome area: Tic disorder (TD) is a group of neuropsychiatric disorders that are characterized by involuntary, purposeless, stereotyped, non-rhythmic movements and/or vocalizations due to the sudden and involuntary contractions of one or more muscles. It often occurs with various psychopathological and/or behavioral comorbidities, including obsessive-compulsive disorder (OCD), attention deficit hyperactivity disorder (ADHD), anxiety and depression. According to the DSM-5 (2013), TD is divided into four main2021-06-05 · Subject: Vitamin d; 24,25-Dihydroxyvitamin D; (3R,6R)-6-[(1R,3aS,7aR)-4-[2-[(5S)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol; (6R)-6-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(5R)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol; 24,25-dihydroxyvitamin D3; 24,25-Dihydroxycholecalciferol; 24,25-dihydroxyvitamin; CHEBI:89324; Q27161510; (3b,5Z,7E)-9,10-Secocholesta-5, · open the ingredient record
-
Systematic review registration CRD42021231688 Registered protocol, no results here: Review OngoingVitamin D and Attention Deficit Hyperactivity Disorder in Children: A Meta-analysis of Blood Levels and Intervention EffectsCondition or outcome area: Attention deficit hyperactivity disorder (ADHD) is a childhood-onset mental health disorder with behavioral abnormalities such as difficulties in paying attention, concentrating, and controlling emotions, and excessive indulgence in daily activities. ADHD as the most common neuropsychiatric disorder in children prevents their normal development by interrupting regular life activities.Therefore, ADHD can considerably exert a widespan of adverse effects on the life quality of children and their fa2021-02-17 · Subject: Vitamin d; 24,25-Dihydroxyvitamin D; (3R,6R)-6-[(1R,3aS,7aR)-4-[2-[(5S)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol; (6R)-6-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(5R)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol; 24,25-dihydroxyvitamin D3; 24,25-Dihydroxycholecalciferol; 24,25-dihydroxyvitamin; CHEBI:89324; Q27161510; (3b,5Z,7E)-9,10-Secocholesta-5, · open the ingredient record
-
Systematic review registration CRD42020209832 Registered protocol, no results here: Review OngoingVitamin D supplementation and its impact on depression in adults: Systematic review and meta-analysisCondition or outcome area: Depressive disorders are highly prevalent and are among the leading causes of disability worldwide. The estimated lifetime prevalence of depression is 12%. This number is even higher in patients with medical illnesses like diabetes or coronary heart disease, in which the prevalence of major depression is 10 to 20%. In the primary care setting, depression affects 5 to 10% of patients and most patients are treated by primary care physicians rather than psychiatrists. Clinical practice guidelines2020-10-18 · Subject: Vitamin d; 24,25-Dihydroxyvitamin D; (3R,6R)-6-[(1R,3aS,7aR)-4-[2-[(5S)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol; (6R)-6-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(5R)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol; 24,25-dihydroxyvitamin D3; 24,25-Dihydroxycholecalciferol; 24,25-dihydroxyvitamin; CHEBI:89324; Q27161510; (3b,5Z,7E)-9,10-Secocholesta-5, · open the ingredient record
-
Publication PMID 32076408 Research model: Animal ExperimentA Chinese Prescription Yu-Ping-Feng-San Administered in Remission Restores Bronchial Epithelial Barrier to Inhibit House Dust Mite-Induced Asthma RecurrenceCondition or outcome area: DSG1 deficiency; airway hyperresponsiveness; chronic asthma; asthmaFront Pharmacol · 2020 · Subject: Yu Ping Feng San; 玉屏风散; Yu Ping Feng Powder · open the formula record · DOI 10.3389/fphar.2019.01698
-
Publication PMID 18558456 Research model: Clinical ExperimentRepeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortexCondition or outcome area: Alzheimer's disease; senile dementia; dementiaProg Neuropsychopharmacol Biol Psychiatry · 2008 · Subject: YI GAN SAN; 抑肝散; Yi Gan Powder · open the formula record · DOI 10.1016/j.pnpbp.2008.05.010
-
Publication PMID 33986688 Research model: Animal & Cell ExperimentShexiang Baoxin Pill, a Proprietary Multi-Constituent Chinese Medicine, Prevents Locomotor and Cognitive Impairment Caused by Brain Ischemia and Reperfusion Injury in Rats: A Potential Therapy for Neuropsychiatric Sequelae of StrokeCondition or outcome area: cognitive impairment; stroke; Post-stroke cognitive impairment; cardiovascular diseases; Ischemic stroke; middle cerebral artery occlusion; ischemic strokeFront Pharmacol · 2021 · Subject: Shexiang Baoxin Wan; 麝香保心丸; She Xiang Bao Xin Pill; Shexiang Baoxin Pill · open the formula record · DOI 10.3389/fphar.2021.665456
-
Publication PMID 34531740 Research model: Cell ExperimentKakkonto Inhibits Cytokine Production Induced by Rhinovirus Infection in Primary Cultures of Human Nasal Epithelial CellsCondition or outcome area: inflammatory diseases of the upper body; respiratory syncytial virus; tumor; airway inflammation; Rhinovirus; chronic obstructive pulmonary disease; RV infection; shoulder stiffness; bronchial asthmaFront Pharmacol · 2021 · Subject: Ge Gen Tang; 葛根汤; Ge Gen Decoction · open the formula record · DOI 10.3389/fphar.2021.687818
-
Publication PMID 34391441 Research model: Animal ExperimentChaihu-Shugan-San (Shihosogansan) alleviates restraint stress-generated anxiety and depression in mice by regulating NF-κB-mediated BDNF expression through the modulation of gut microbiotaCondition or outcome area: gut dysbiosis; anxiety; Psychiatric disordersChin Med · 2021 · Subject: CHAI HU SHU GAN SAN; 柴胡舒肝散; Chai Hu Shu Gan Powder · open the formula record · DOI 10.1186/s13020-021-00492-5
-
Publication PMID 36558562 Research model: Cell ExperimentRole of Zerumbone, a Phytochemical Sesquiterpenoid from Zingiber zerumbet Smith, in Maintaining Macrophage Polarization and Redox HomeostasisCondition or outcome area: psychiatric disorders; inflammation; neurodegenerative diseases; tumor; neuroinflammatory diseasesNutrients · 2022 · Subject: Zerumbone; 471-05-6; (2E,6E,10E)-2,6,9,9-tetramethylcycloundeca-2,6,10-trien-1-one; (E,E,E)-2,6,9,9-Tetramethyl-2,6,10-cycloundecatrien-1-one; 2E,6E,9E-humulatrien-8-one; CHEBI:63892; CHEMBL245412; Zerumbone (6CI,7CI); erumbone; MFCD03700769 · open the ingredient record · DOI 10.3390/nu14245402
-
Publication PMID 36364807 Research model: Animal ExperimentProtective Effects of Resveratrol on Adolescent Social Isolation-Induced Anxiety-Like Behaviors via Modulating Nucleus Accumbens Spine Plasticity and Mitochondrial Function in Female RatsCondition or outcome area: psychiatric disorders; mood disorders; social dysfunction; adolescent social stress; NAc.; spine abnormalities; SI-induced behavioral abnormalityNutrients · 2022 · Subject: Trans-resveratrol; Resveratrol; resveratrol; 501-36-0; 3,4',5-Trihydroxystilbene; (E)-5-(4-Hydroxystyryl)benzene-1,3-diol; 3,5,4'-Trihydroxystilbene; (E)-resveratrol; Resvida; 3,4',5-Stilbenetriol · open the ingredient record · DOI 10.3390/nu14214542
-
Publication PMID 33968980 Research model: Cell ExperimentResveratrol Improves Mitochondrial Biogenesis Function and Activates PGC-1α Pathway in a Preclinical Model of Early Brain Injury Following Subarachnoid HemorrhageCondition or outcome area: brain injury; brain edema; subarachnoid hemorrhage; neurological impairment; prechiasmatic cistern SAHFront Mol Biosci · 2021 · Subject: Trans-resveratrol; Resveratrol; resveratrol; 501-36-0; 3,4',5-Trihydroxystilbene; (E)-5-(4-Hydroxystyryl)benzene-1,3-diol; 3,5,4'-Trihydroxystilbene; (E)-resveratrol; Resvida; 3,4',5-Stilbenetriol · open the ingredient record · DOI 10.3389/fmolb.2021.620683
-
Publication PMID 33841372 Research model: Animal & Cell ExperimentAnethole Attenuates Enterotoxigenic Escherichia coli- Induced Intestinal Barrier Disruption and Intestinal Inflammation via Modification of TLR Signaling and Intestinal MicrobiotaCondition or outcome area: villous atrophy; intestinal inflammationFront Microbiol · 2021 · Subject: Trans-anethole; Anethole; ANETHOLE; 4180-23-8; 104-46-1; (E)-Anethole; p-Propenylanisole; Anise camphor; Isoestragole; Monasirup · open the ingredient record · DOI 10.3389/fmicb.2021.647242
-
Publication PMID 35000533 Research model: Cell ExperimentTaxifolin improves inflammatory injury of human bronchial epithelial cells by inhibiting matrix metalloproteinase (MMP) 10 via Wnt/β-catenin pathwayCondition or outcome area: asthma; respiratory diseasesBioengineered · 2022 · Subject: Taxifolin; 480-18-2; (+)-Taxifolin; dihydroquercetin; Distylin; Taxifoliol; 24198-97-8; (2R,3R)-Dihydroquercetin; (+)-Dihydroquercetin; Lavitol · open the ingredient record · DOI 10.1080/21655979.2021.2018384
-
Publication PMID 36216079 Research model: Animal ExperimentTangeretin prevents cognitive deficit in delirium through activating RORα/γ-E4BP4 axis in miceCondition or outcome area: cognitive deficiency; neuropsychiatric syndrome; Delirium; cognitive impairment; delirium; acute cognitive and attentional deficitsBiochem Pharmacol · 2022 · Subject: Tangeretin; 481-53-8; Tangeritin; Ponkanetin; Pentamethoxyflavone; 4',5,6,7,8-Pentamethoxyflavone; 5,6,7,8,4'-Pentamethoxyflavone; 4H-1-Benzopyran-4-one, 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-; 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)chromen-4-one; 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one · open the ingredient record · DOI 10.1016/j.bcp.2022.115286
-
Publication PMID 34033999 Research model: Cell ExperimentSulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 Spike proteinCondition or outcome area: Acute Respiratory Distress Syndrome; SARS-CoV-2 infectionPhytomedicine · 2021 · Subject: Sulforathane; Sulforaphane; sulforaphane; 4478-93-7; DL-Sulforaphane; 1-Isothiocyanato-4-(methylsulfinyl)butane; D,L-Sulforaphane; Sulforafan; 1-isothiocyanato-4-methylsulfinylbutane; 1-Isothiocyanato-4-(methylsulfinyl)-butane · open the ingredient record · DOI 10.1016/j.phymed.2021.153583
-
Publication PMID 32710977 Research model: Animal ExperimentSulforaphane alleviates ethanol-mediated central inhibition and reverses chronic stress-induced aggravation of acute alcoholism via targeting Nrf2-regulated catalase expressionCondition or outcome area: acute ethanol intoxication; alcohol-induced death; alcohol abuse; acute alcoholism; Acute ethanol intoxication; psychiatricNeuropharmacology · 2020 · Subject: Sulforathane; Sulforaphane; sulforaphane; 4478-93-7; DL-Sulforaphane; 1-Isothiocyanato-4-(methylsulfinyl)butane; D,L-Sulforaphane; Sulforafan; 1-isothiocyanato-4-methylsulfinylbutane; 1-Isothiocyanato-4-(methylsulfinyl)-butane · open the ingredient record · DOI 10.1016/j.neuropharm.2020.108235
-
Publication PMID 31762213 Research model: Animal ExperimentProteomics-based screening of the target proteins associated with antidepressant-like effect and mechanism of Saikosaponin ACondition or outcome area: chronic unpredictable mild stress; neuropsychiatric diseaseJ Cell Mol Med · 2020 · Subject: Saikosaponin a; Saikosaponin A; 20736-09-8; UNII-09O6CAG7JV; 09O6CAG7JV; CHEBI:8996; (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-3,5-dihydroxy-2-[[(1S,2S,4S,5R,8R,9R,10S,13S,14R,17S,18R)-2-hydroxy-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracos-15-en-10-yl]oxy]-6-methyloxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; beta-D-Galactopyranoside, (3beta,4alpha,16beta)-13,28-epoxy-16,23-dihydroxyolean-11-en-3-yl-6-deoxy-3-O-beta-D-glucopyranosyl-; beta-D- · open the ingredient record · DOI 10.1111/jcmm.14695
-
Publication PMID 32002777 Research model: Animal & Cell ExperimentNeuroprotective Effects of Salidroside in a Mouse Model of Alzheimer's DiseaseCondition or outcome area: Alzheimer's disease; cognitive impairment; psychiatry disorders; dementiaCell Mol Neurobiol · 2020 · Subject: P-hydroxyphenethyl-beta-d-glucoside; Salidroside; 10338-51-9; Rhodioloside; Rhodosin; sallidroside; salidroside, (-)-; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[2-(4-hydroxyphenyl)ethoxy]oxane-3,4,5-triol; Glucopyranoside, p-hydroxyphenethyl; Tyrosol glucoside · open the ingredient record · DOI 10.1007/s10571-020-00801-w
-
Publication PMID 35185541 Research model: Cell ExperimentNetwork Pharmacology-Based and Experimental Identification of the Effects of Paeoniflorin on Major Depressive DisorderCondition or outcome area: intestinal inflammation; Major depressive disorder; psychiatric disordersFront Pharmacol · 2022 · Subject: Paeoniflorin; Peoniflorin; 23180-57-6; Paeonia moutan; NSC 178886; UNII-21AIQ4EV64; 21AIQ4EV64; CCRIS 6494; EINECS 245-476-2; Paeoniflorin (>80%) · open the ingredient record · DOI 10.3389/fphar.2021.793012
-
Publication PMID 30262887 Research model: Clinical & Animal ExperimentNeurochemical evidence for differential effects of acute and repeated oxytocin administrationCondition or outcome area: autism spectrum disorderMol Psychiatry · 2021 · Subject: Oxytocin; 50-56-6; Pitocin; Endopituitrina; Ocytocin; Syntocinon; Oxytocinum; Orasthin; Oxystin; alpha-Hypophamine · open the ingredient record · DOI 10.1038/s41380-018-0249-4
-
Publication PMID 32989216 Research model: Animal & Cell ExperimentN,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivoTransl Psychiatry · 2020 · Subject: N,n-dimethyltryptamine; Dimethyltryptamine; DIMETHYLTRYPTAMINE; 61-50-7; 2-(3-Indolyl)ethyldimethylamine; 3-(2-Dimethylaminoethyl)indole; 1H-Indole-3-ethanamine, N,N-dimethyl-; 2-(1H-Indol-3-yl)-N,N-dimethylethanamine; N,N-Dimethyl-1H-indole-3-ethylamine; DMT (psychogenic) · open the ingredient record · DOI 10.1038/s41398-020-01011-0
-
Publication PMID 31413370 Research model: Animal ExperimentMorphine coordinates SST and PV interneurons in the prelimbic cortex to disinhibit pyramidal neurons and enhance rewardCondition or outcome area: hyper-locomotionMol Psychiatry · 2021 · Subject: Morphine; Morphia; Morphium; Morphin; Morphinum; (-)-Morphine; Morphina; Ospalivina; Duromorph; 57-27-2 · open the ingredient record · DOI 10.1038/s41380-019-0480-7
-
Publication PMID 35295707 Research model: Animal & Cell ExperimentQuercetin Mitigates Methamphetamine-Induced Anxiety-Like Behavior Through Ameliorating Mitochondrial Dysfunction and NeuroinflammationCondition or outcome area: psychiatric disorders; mitochondrial dysfunction; increased anxiety; mitochondrial impairment; anxietyFront Mol Neurosci · 2022 · Subject: Quercetin; 117-39-5; Sophoretin; Meletin; Quercetine; Xanthaurine; Quercetol; Quertine; Quercitin; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one · open the ingredient record · DOI 10.3389/fnmol.2022.829886
-
Publication PMID 35010945 Research model: Cell ExperimentRegulatory Effects of Quercetin on M1/M2 Macrophage Polarization and Oxidative/Antioxidative BalanceCondition or outcome area: adipose tissue inflammation; psychiatric disorders; inflammation; neurodegenerative diseases; tumor; Neuroinflammation; atherosclerosis; Homeostasis dysfunction; inflammatory disordersNutrients · 2021 · Subject: Quercetin; 117-39-5; Sophoretin; Meletin; Quercetine; Xanthaurine; Quercetol; Quertine; Quercitin; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one · open the ingredient record · DOI 10.3390/nu14010067
-
Publication PMID 33908633 Research model: Animal ExperimentQuercetin relieves D-amphetamine-induced manic-like behaviour through activating TREK-1 potassium channels in miceCondition or outcome area: manic hyperlocomotion; cognition deficits; psychiatric disorders; memory dysfunctionBr J Pharmacol · 2021 · Subject: Quercetin; 117-39-5; Sophoretin; Meletin; Quercetine; Xanthaurine; Quercetol; Quertine; Quercitin; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one · open the ingredient record · DOI 10.1111/bph.15510
-
Publication PMID 31987923 Research model: Animal ExperimentDepressive-like phenotype evoked by lifelong nutritional omega-3 deficiency in female rats: Crosstalk among kynurenine, Toll-like receptors and amyloid beta oligomersCondition or outcome area: Alzheimer's disease; depressive like- symptoms; psychiatric diseases; depressive-like symptoms; neurodegenerative illnessesBrain Behav Immun · 2020 · Subject: Kynurenine; 343-65-7; dl-Kynurenine; 2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid; rac Kynurenine; 3-Anthraniloylalanine; 3-Anthraniloyl-DL-alanine; Alanine, 3-anthraniloyl-; (+-)-Kynurenine; (+/-)-Kynurenine · open the ingredient record · DOI 10.1016/j.bbi.2020.01.015
-
Publication PMID 36142129 Research model: Animal & Cell ExperimentIcariin Alleviates Escherichia coli Lipopolysaccharide-Mediated Endometritis in Mice by Inhibiting Inflammation and Oxidative StressCondition or outcome area: Endometritis; uterine disease; endometritisInt J Mol Sci · 2022 · Subject: Icariin; 489-32-7; Ieariline; CHEBI:78420; UNII-VNM47R2QSQ; VNM47R2QSQ; 5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one; Icariine; Epimedii herba icariin; MFCD00210516 · open the ingredient record · DOI 10.3390/ijms231810219
-
Publication PMID 32321531 Research model: Cell ExperimentAlantolactone suppresses inflammation, apoptosis and oxidative stress in cigarette smoke-induced human bronchial epithelial cells through activation of Nrf2/HO-1 and inhibition of the NF-κB pathwaysCondition or outcome area: chronic obstructive pulmonary disease; inflammationRespir Res · 2020 · Subject: Helenine; Alantolactone; 546-43-0; helenin; Eupatal; Alant camphor; Inula camphor; Elecampane camphor; CHEBI:2540; AI3-31147 · open the ingredient record · DOI 10.1186/s12931-020-01358-4
-
Publication PMID 34721013 Research model: Cell ExperimentHederagenin Protects PC12 Cells Against Corticosterone-Induced Injury by the Activation of the PI3K/AKT PathwayCondition or outcome area: psychiatric disorderFront Pharmacol · 2021 · Subject: Hederagenin; 465-99-6; Caulosapogenin; Hederagenol; Astrantiagenin E; Hederagenic acid; Hederagenine; NSC 24954; 4-epi-hederagenin; EINECS 207-369-9 · open the ingredient record · DOI 10.3389/fphar.2021.712876
-
Publication PMID 32224881 Research model: Animal ExperimentBifidobacteria-Fermented Red Ginseng and Its Constituents Ginsenoside Rd and Protopanaxatriol Alleviate Anxiety/Depression in Mice by the Amelioration of Gut DysbiosisCondition or outcome area: gut dysbiosis; psychiatric disorders; 2,4,6-trinitrobenzenesulfonic acid-induced colitis; anxiety; Gut dysbiosis; colitisNutrients · 2020 · Subject: Ginsenoside rd; Ginsenoside Rd; 52705-93-8; Chikusetsusaponin FK7; Gypenoside VIII; UNII-WB232T95AV; WB232T95AV; GS-Rd; CHEBI:67988; G-Rd · open the ingredient record · DOI 10.3390/nu12040901
-
Publication PMID 35565807 Research model: Animal & Cell ExperimentFisetin Suppresses the Inflammatory Response and Oxidative Stress in Bronchial Epithelial CellsCondition or outcome area: asthma; airway hyperresponsiveness; tumor; inflammationNutrients · 2022 · Subject: Fisetin; 528-48-3; 5-Desoxyquercetin; 2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-4H-chromen-4-one; 3,3',4',7-Tetrahydroxyflavone; Fustel; Viset; 3,7,3',4'-Tetrahydroxyflavone; Fisetholz; Superfustel · open the ingredient record · DOI 10.3390/nu14091841
-
Publication PMID 32795541 Research model: Cell ExperimentEpigallocatechin gallate diminishes cigarette smoke-induced oxidative stress, lipid peroxidation, and inflammation in human bronchial epithelial cellsCondition or outcome area: chronic obstructive pulmonary diseaseLife Sci · 2020 · Subject: (-)-epigallocatechin-3-gallate; Epigallocatechin Gallate; (-)-Epigallocatechin gallate; EGCG; 989-51-5; Epigallocatechin gallate; Epigallocatechin 3-gallate; Tea catechin; Epigallocatechin-3-gallate; Teavigo · open the ingredient record · DOI 10.1016/j.lfs.2020.118260
-
Publication PMID 34636389 Research model: Animal ExperimentProphylactic treatment of curcumin in a rat model of depression by attenuating hippocampal synaptic lossCondition or outcome area: neuropsychiatric disorders; neurodegenerative diseases; major depressive disorderFood Funct · 2021 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record · DOI 10.1039/d1fo02676c